Cabaletta Bio (CABA) Net Income towards Common Stockholders Growth (3y) (2021 - 2025)
Cabaletta Bio (CABA) Net Income towards Common Stockholders Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-10.84% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
26.38% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
34.98% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Cabaletta Bio |
158.47 Mn |
24.88 Mn |
- |
-38.67% |
| Date | Value |
|---|
| Dec 31, 2025 |
-38.67% |
| Sep 30, 2025 |
-58.34% |
| Jun 30, 2025 |
-51.70% |
| Mar 31, 2025 |
-40.55% |
| Dec 31, 2024 |
-32.88% |
| Sep 30, 2024 |
-38.38% |
| Jun 30, 2024 |
-35.32% |
| Mar 31, 2024 |
-37.18% |
| Dec 31, 2023 |
-30.91% |
| Sep 30, 2023 |
-25.14% |
| Jun 30, 2023 |
-21.13% |
| Mar 31, 2023 |
-28.42% |
| Dec 31, 2022 |
-42.67% |
| Sep 30, 2022 |
-34.95% |
| Jun 30, 2022 |
-56.66% |
| Mar 31, 2022 |
-13.48% |
| Dec 31, 2021 |
-93.90% |
| Sep 30, 2021 |
-7.61% |
